Oemrawsingh, Rohit M <br/><br/>
Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  Aug 2016 
 - 734-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJV12I6A118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Coronary Artery Disease--blood<br/>Coronary Vessels--diagnostic imaging<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Rosuvastatin Calcium--pharmacology<br/>Spectroscopy, Near-Infrared<br/>Ultrasonography, Interventional